Source link : https://newshealth.biz/health-news/fda-reverses-course-on-neuro-drugs-omega-3s-and-dementia-brain-death-test-lawsuit/
Gene therapy developer uniQure said it will submit a marketing application for accelerated approval for investigational AMT-130 for Huntington’s disease after the FDA reversed its position and agreed that a 3-year analysis of a phase I/II study showing benefit was acceptable. The FDA also will reconsider clemidsogene lanparvovec — an investigational gene therapy for mucopolysaccharidosis […]
The post FDA Reverses Course on Neuro Drugs; Omega-3s and Dementia; Brain Death Test Lawsuit first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-23 18:14:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8